Novo Nordisk A/S
CSE:NOVO B
Novo Nordisk A/S
CSE:NOVO B
Price:
903.3 DKK
-1.05%
Market Closed
Updated:
May 19, 2024
Novo Nordisk A/S
Other Current Liabilities
|
Novo Nordisk A/S
Other Current Liabilities Peer Comparison
Comparables:
HLUN A
ALK B
Competitive Other Current Liabilities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Other Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Novo Nordisk A/S
CSE:NOVO B
|
Other Current Liabilities
kr142.4B
|
CAGR 3-Years
34%
|
CAGR 5-Years
24%
|
CAGR 10-Years
20%
|
|
|
H Lundbeck A/S
CSE:HLUN A
|
Other Current Liabilities
kr3.5B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
ALK-Abello A/S
CSE:ALK B
|
Other Current Liabilities
kr216m
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
N/A
|
See Also
What is Novo Nordisk A/S's Other Current Liabilities?
Other Current Liabilities
142.4B
DKK
142.4B
DKK
Based on the financial report for Mar 31, 2024, Novo Nordisk A/S's Other Current Liabilities amounts to 142.4B DKK.
What is Novo Nordisk A/S's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 10Y
20%
20%
Over the last year, the Other Current Liabilities growth was 18%. The average annual Other Current Liabilities growth rates for Novo Nordisk A/S have been 34% over the past three years , 24% over the past five years , and 20% over the past ten years .
You don't have any saved screeners yet
